0001885582-21-000001.txt : 20211004
0001885582-21-000001.hdr.sgml : 20211004
20211004100529
ACCESSION NUMBER: 0001885582-21-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20211004
DATE AS OF CHANGE: 20211004
EFFECTIVENESS DATE: 20211004
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lowell Therapeutics, Inc
CENTRAL INDEX KEY: 0001885582
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-415500
FILM NUMBER: 211301301
BUSINESS ADDRESS:
STREET 1: 110 CANAL STREET
CITY: LOWELL
STATE: MA
ZIP: 01852
BUSINESS PHONE: (978) 649-4841
MAIL ADDRESS:
STREET 1: 110 CANAL STREET
CITY: LOWELL
STATE: MA
ZIP: 01852
D
1
primary_doc.xml
X0708
D
LIVE
0001885582
Lowell Therapeutics, Inc
110 CANAL STREET
3RD FLOOR
LOWELL
MA
MASSACHUSETTS
01852
(978) 649-4841
DELAWARE
None
None
Corporation
true
2018
JAMES
WILKIE
110 CANAL STREET
3RD FLOOR
LOWELL
MA
MASSACHUSETTS
01852
Executive Officer
Director
Biotechnology
Decline to Disclose
- 06b
false
2021-09-20
false
true
false
0
7000000
3846296
3153704
Additional shares to be sold at subsequent closings.
false
7
0
0
0
false
Lowell Therapeutics, Inc
/s/ James Wilkie
James Wilkie
President
2021-10-01